NeuroScientific Biopharmaceuticals Company Description

NeuroScientific Biopharmaceuticals Limited engages in the research and development of novel peptide-based pharmaceutical products.

The company is involved in the development of therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies.

Its lead drug candidates include EmtinB for treatment of neurodegenerative Alzheimer’s disease, multiple scierosis, glaucoma, optic nerve atrophy, and other diseases.

The company was incorporated in 2002 and is based in Perth, Australia.

NeuroScientific Biopharmaceuticals Limited

Country	Australia
Founded	2002
Industry	Biotechnology
Sector	Healthcare

Contact Details

Address: 216 St Georges Terrace Perth, 6000 Australia
Phone	61 8 6268 2641
Website	neuroscientific.com

Stock Details

Ticker Symbol	NSB
Exchange	Australian Securities Exchange
Fiscal Year	July - June
Reporting Currency	AUD
ISIN Number	AU0000012973
SIC Code	2836

Key Executives

Name	Position
Dr. Anthony James Keating	Executive Director
Christopher Bryan James Achurch B.Com., C.A.	Company Secretary